RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All TITCK (Turkey) updates
TITCK (Turkey)
NOTICE
ANKARA İL SAĞLIK MÜDÜRÜ UZM. DR. ALİ NİYAZİ KURTCEBE TİTCK BAŞKANI PROF. DR. AHMET AYAR'I MAKAMINDA ZİYARET ETTİ - 1553
Published: 8/14/2025Detected: 3/25/2026

Summary preview

Records a visit by Ankara Provincial Health Director Dr. Ali Niyazi Kurtcebe to TITCK President Prof. Dr. Ahmet Ayar.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
manufacturing
quality
clinical
safety
labeling
#TİTCK
#Ankara
#provincial health directorate
#regulatory engagement
#notice

Official Source Document
Source Verified

Access the original document directly from TITCK.

View Official Document

More from TITCK (Turkey)

  • 01.06.2026 TARİHLİ RESMİ GAZETEDE YAYIMLANAN 16 ADET SÖZLEŞMELİ PERSONEL ALIMINA İLİŞKİN İTİRAZ DEĞERLENDİRME SONUÇLARI VE BAŞVURU DEĞERLENDİRME SONUÇLARI - 53508/18/2026
  • Kamuoyunun Dikkatine - 53498/18/2026
  • EDQM 2028–2031 Orta Vadeli Stratejisine Katkı Sağlamak Üzere Paydaş Anketi - 53488/17/2026
  • İLAÇ FİRMALARININ DİKKATİNE - 53478/13/2026
  • İLAÇ FİRMALARININ DİKKATİNE - 53468/13/2026

Get TITCK (Turkey) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.